Evidence map›Paper›PMID 23329339›Full record

ArticleThe Journal of membrane biology2013

Hemolytic activity of membrane-active peptides correlates with the thermodynamics of binding to 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine bilayers.

B Logan Spaller, Julie M Trieu, Paulo F Almeida

Open access · greenAbstract read
In one paragraph

Article in The Journal of membrane biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

B Logan SpallerDepartment of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, NC 28403, USA.
Julie M Trieu
Paulo F Almeida
University of North Carolina Wilmington · US

Funding

Mechanisms of amphipathic and cargo delivery peptidesR15GM072507 · NIGMS · UNIVERSITY OF NORTH CAROLINA WILMINGTON · PI ALMEIDA, PAULO F · 2005 to 2012
$758k
NIGMS NIH HHS GM072507NIGMS NIH HHS R15 GM072507
6 · The paper itself

Abstract

Understanding the mechanisms of antimicrobial, cytolytic and cell-penetrating peptides is important for the design of new peptides to be used as cargo-delivery systems or antimicrobials. But these peptides should not be hemolytic. Recently, we designed a series of such membrane-active peptides and tested several hypotheses about their mechanisms on model membranes. To that end, the Gibbs free energy of binding to 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) vesicles was determined experimentally. Because the main lipid components of the outermost monolayer of erythrocyte membranes are zwitterionic, like POPC, we hypothesized that the Gibbs free energy of binding of these peptides to POPC would also be a good indicator of their hemolytic activity. Now, the hemolytic activity of those synthetic peptides was examined by measuring the lysis of sheep erythrocyte suspensions after peptide addition. Indeed, the Gibbs free energy of binding was in good correlation with the hemolytic activity, which was represented by the concentration of peptide in solution that produced 50 % hemolysis. Furthermore, with two exceptions, those peptides that caused graded dye release from POPC vesicles were also hemolytic, while most of those that caused all-or-none release were not.

Indexed as

ThermodynamicsAnimalsAntimicrobial Cationic PeptidesCell-Penetrating PeptidesHemolysisLipid BilayersPhosphatidylcholinesProtein BindingSheep1-palmitoyl-2-oleoylphosphatidylcholineAntimicrobial Cationic PeptidesCell-Penetrating PeptidesLipid BilayersPhosphatidylcholines

Identifiers

PMID23329339
PMCPMC3584441
OpenAlexW2043166016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.